100 days with John Crowley: Behind BIO’s new structure & vision
Jun 25, 2024 · With only a little more than 100 days at the helm, BIO CEO John Crowley has already implemented a restructure and taken a stance on U.S. biosecurity.
BIO CEO John Crowley interview: China, vaccines, and Trump - STAT
Jul 18, 2024 · W ASHINGTON — BIO’s new CEO John Crowley is making changes. He’s pivoting the biotechnology industry’s largest trade association away from a focus on controversial …
100 days with John Crowley: BIO’s new vision and a ‘wake-up call’ …
Oct 7, 2024 · With only a little more than three months at the helm of the world’s largest biotech advocacy group, the leader has already implemented a wide-scale restructure and taken a firm …
New Pompe disease treatment 'exciting,' Amicus chairman says
Nov 9, 2023 · Bringing a third medication for late-onset Pompe disease (LOPD) to the treatment table is a personal triumph for Amicus Therapeutics executive chairman John Crowley.
Admiral William H. McRaven speaks at BIO 2024 - Bio.News
Jun 5, 2024 · Admiral William H. McRaven sat down with BIO President & CEO John F. Crowley at the 2024 BIO Convention to discuss leadership and hope.
BIO selects John Crowley as new CEO - STAT
Dec 5, 2023 · W ASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John Crowley as its new CEO, the …
BIO names longtime Amicus head John Crowley as new CEO
Dec 5, 2023 · The Biotech Innovation Organization on Tuesday named Amicus Therapeutics co-founder and longtime leader John Crowley as its new CEO, taking over a spot interim chief …
John F. Crowley at GEN State of Biotechnology 2024 - Bio.News
Sep 13, 2024 · John F. Crowley, President & CEO of the Biotechnology Innovation Organization (BIO), gave a keynote about BIO’s work, how the current political landscape is affecting the …
BIO CEO urges innovation in access at White House CGT forum
Jan 13, 2025 · As science progresses, we need parallel progress in making breakthrough treatments widely available, BIO President & CEO John F. Crowley said at a Jan. 8 White …
BIO names John Crowley as new CEO
Dec 5, 2023 · John Crowley’s resume, in a nutshell: He’s currently the founder and executive chairman of Amicus Therapeutics, which develops treatments for rare genetic diseases. He …